T102C genetic polymorphism of the 5-HT2A receptor in Chinese hypertensive patients and healthy controls

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 12, 2004, Pages 847-849

  Yu, Bang Ning ^a   Wang, An ^a   Zhou, Gan ^a   Zhang, Wei ^a   Hu, Dong Ii ^a   Li, Qing ^a   He, Yi Jing ^a   Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

5 HT2A receptor; Gender; Genetic polymorphism; Hypertension; Polymerase chain reaction; T102C

Indexed keywords

SEROTONIN 2A RECEPTOR;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 11144244767     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04124.x     Document Type: Article

References (15)

1. 2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. Lancet 1997; 349: 1221.
2. Williams J, Spurlock G, McGuffin P et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 1996; 347: 1294-6.
3. Vanhoutte PM. Serotonin, hypertension and vascular disease. Neth. J. Med. 1991; 38: 35-42.
4. Singh NK, Goyal R. New classes of antihypertensive drugs: Therapeutic potentials. Clin. Exp. Hypertens. 1999; 21: 137-43.
5. Liolitsa D, Powell JF, Prince M, Lovestone S. Association study of the 5-HT(2A) receptor gene polymorphism, T102C, and essential hypertension. J. Hum. Hypertens. 2001; 15: 335-9.
6. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor. 1989.
7. 2A receptor gene. Lancet 1995; 346: 281-2.
8. Busjahn A, Li GH, Faulhaber HD et al. Beta-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins. J. Hypertens. 2000; 14: 1195-9.
9. Candy G, Samani N, Norton G et al. Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population. J. Hypertens. 2000; 18: 167-72.
10. Bengtsson K, Melander O, Orho-Melander M et al. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 2001; 104: 187-90.
11. Liu Y, Zhuoma C, Shan G et al. A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations. Hypertens. Res. 2002; 25: 515-21.
12. Jindra A, Horky K, Peleska J et al. Association analysis of Arg16Gly polymorphism of the beta2-adrenergic receptor gene in offspring from hypertensive and normotensive families. Blood Pressure 2002; 11: 213-17.
13. Humphrey PP, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 1993; 14: 233-6.
14. Hoyer D, Clarke DE, Fozard JR et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 1994; 46: 157-203.
15. Van Zwieten PA, Blauw GJ, van Brummelen P. Serotonergic receptors and drugs in hypertension. Pharmacol. Toxicol. 1992; 70 (Suppl.): S17-22.